In recognition of the rising prevalence of diabetes in the United States, especially among older adults, the Endocrine Society has published a new clinical practice guideline for the treatment of diabetes...
In a recent study, researchers sought to explore the effects of concomitant use of GLP-1 receptor agonists with SGLT-2 inhibitors in patients with poorly controlled type 2 diabetes.
In a recent study, researchers sought to estimate the long-term risk of cardiovascular disease based on fasting glucose levels that are below the threshold of diabetes.
While it is already known that ideal cardiovascular health is associated with lower risk of diabetes, whether this association persists across glycemic levels is unknown.
The American College of Cardiology has released new guidance on the use of therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have released an updated consensus statement on the management of hyperglycemia in patients with type 2...
Because of the relationship between bodyweight and the risk of diabetes, researchers sought to examine the long-term effects of a selective serotonin 2C receptor agonist and appetite-suppressant drug which...
In a recent study, researchers sought to evaluate the impact of treatment with a glucagon-like peptide 1 receptor agonist on rates of cardiovascular events in patients with type 2 diabetes and...
